30
300562.SHE Guangdong Transtek Medical Electronics Co Ltd
- Market cap
- CNY 2.73B
- P/E
- 27.1x
- P/B
- 2.39x
- ROE
- 10.1%
- Dividend yield
- 2.32%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300562.SHE undervalued?
Graham number300562.SHE trades 69.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Guangdong Transtek Medical Electronics Co Ltd fundamental analysis
No fundamental analysis for Guangdong Transtek Medical Electronics Co Ltd yet.
Guangdong Transtek Medical Electronics Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Guangdong Transtek Medical Electronics Co Ltd
Guangdong Transtek Medical Electronics Co., Ltd. engages in the research and development, design, manufacturing, operation services, and sales of monitoring equipment. The company offers health products, including smart electronic blood pressure monitors, smart electronic blood pressure monitors, electronic health scales, smart blood glucose monitors, body fat analyzers, smart wearable devices, and other terminals. It also provides products and solutions for blood pressure m…
Full company profileGuangdong Transtek Medical Electronics Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Guangdong Transtek Medical Electronics Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 771M | 867M | 775M | 884M | 1.34B | 1.82B | 1.07B | 884M | 984M | 986M | 1.09B |
| Gross Profit | 255M | 235M | 198M | 216M | 335M | 335M | 221M | 278M | 338M | 351M | 393M |
| Operating Income | 83.9M | 12.3M | 26.5M | 37.6M | 72.2M | 85.2K | -41.1M | 34.5M | 58.4M | 106M | 151M |
| EBITDA | 109M | 35.6M | 41.2M | 52.5M | 87.8M | 18.7M | -17.3M | 61.8M | 86.1M | 113M | 121M |
| Net Income | 80.5M | 17.8M | 24.0M | 31.1M | 70.2M | 8.87M | -32.4M | 34.4M | 61.4M | 82.0M | 113M |
| EPS | 0.55 | 0.09 | 0.13 | 0.16 | 0.37 | 0.04 | -0.15 | 0.16 | 0.28 | 0.38 | 0.51 |
| Balance Sheet | |||||||||||
| Total Assets | 662M | 755M | 879M | 982M | 1.38B | 1.79B | 1.55B | 1.56B | 1.51B | 1.39B | 1.50B |
| Total Liabilities | 156M | 241M | 347M | 414M | 728M | 747M | 548M | 532M | 536M | 388M | 405M |
| Shareholders' Equity | 506M | 512M | 531M | 568M | 654M | 1.05B | 1.01B | 1.04B | 996M | 1.02B | 1.11B |
| Cash & Short-term Investments | 320M | 150M | 297M | 317M | 327M | 537M | 655M | 678M | 764M | 703M | 114M |
| Total Debt | 3.29M | 29.1M | 22.0M | 33.5M | 40.9M | 37.5M | 144M | 131M | 185M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 78.2M | -4.10M | 85.2M | 75.0M | 78.0M | -881K | 84.7M | 74.1M | 119M | 153M | - |
| Capital Expenditure | 57.9M | 79.2M | 24.9M | 31.7M | 99.3M | 67.8M | 21.0M | 12.9M | 28.0M | 14.5M | 16.9M |
| Free Cash Flow | 20.3M | -83.3M | 60.3M | 43.2M | -21.3M | -68.7M | 63.6M | 61.2M | 90.9M | 138M | 141M |
| Ratios | |||||||||||
| ROE | 15.9% | 3.5% | 4.5% | 5.5% | 10.7% | 0.8% | -3.2% | 3.3% | 6.2% | 8.0% | 10.1% |
| ROA | 12.2% | 2.4% | 2.7% | 3.2% | 5.1% | 0.5% | -2.1% | 2.2% | 4.1% | 5.9% | 7.5% |
| Net Profit Margin | 10.4% | 2.1% | 3.1% | 3.5% | 5.2% | 0.5% | -3.0% | 3.9% | 6.2% | 8.3% | 10.3% |
| Debt to Equity | 0.01x | 0.06x | 0.04x | 0.06x | 0.06x | 0.04x | 0.14x | 0.13x | 0.19x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Guangdong Transtek Medical Electronics Co Ltd dividends
- Dividend yield
- 2.32%
- Forward dividend
- 0.26 CNY
- Payout ratio
- 77.2%
- Ex-dividend date
- Oct 15, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 63.3M | 0.29 | 77.2% |
| 2024 | CNY 65.2M | 0.30 | 106.3% |
| 2023 | CNY 2.15M | 0.01 | 6.2% |
| 2022 | CNY 2.15M | 0.01 | - |
| 2021 | CNY 42.9M | 0.19 | 484.1% |
| 2020 | CNY 4.19M | 0.02 | 6.0% |
| 2019 | CNY 3.23M | 0.02 | 10.4% |
| 2018 | CNY 5.50M | 0.03 | 22.9% |
| 2017 | CNY 12.3M | 0.06 | 68.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 32:10 on Apr 18, 2017.
Who owns Guangdong Transtek Medical Electronics Co Ltd
- Insiders 34.09%
- Institutions 1.86%
- Public & others 64.06%
- Shares outstanding 219M
- Free float 147M
Guangdong Transtek Medical Electronics Co Ltd company profile
- Company name
- Guangdong Transtek Medical Electronics Co Ltd
- Ticker
- 300562.SHE
- ISIN
- CNE100002DJ6
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,089
- Fiscal year end
- December
- Address
- East Zone, Fiyta Technology Building, Shenzhen, China
- Phone
- 86 760 8828 2982
- Website
- lifesense.com
About Guangdong Transtek Medical Electronics Co Ltd
Guangdong Transtek Medical Electronics Co., Ltd. engages in the research and development, design, manufacturing, operation services, and sales of monitoring equipment. The company offers health products, including smart electronic blood pressure monitors, smart electronic blood pressure monitors, electronic health scales, smart blood glucose monitors, body fat analyzers, smart wearable devices, and other terminals. It also provides products and solutions for blood pressure management, blood glucose management, heart health, intelligent sports and health, and weight management. Guangdong Transtek Medical Electronics Co., Ltd. was founded in 2000 and is headquartered in Shenzhen, China.
Guangdong Transtek Medical Electronics Co Ltd management
4- Mr. Zhigang PanGM & Director · born 1982
- Ms. Rong WuChief Financial Officer · born 1983
- Ms. Wei LiDeputy GM & Secretary of the Board · born 1991
- Xiaofei WangAccounting Supervisor